Observational data from practitioner-supervised use, even informal, contribute to the pre-clinical-to-clinical evidence bridge that BPC-157 currently lacks
Dihexa is sold strictly for in vitro laboratory research
They are supplied strictly for laboratory and academic research and are not for human consumption, diagnosis, or treatment
All studies were also cross-sectional in nature, which limits conclusions that can be drawn
The two also have slightly different recommendations for dosing, particularly around combining them with food, which may influence when you choose to take them
Peripheral arterial disease and critical limb ischemia represent potential applications based on BPC-157's pro-angiogenic effects and demonstrated improvements in blood flow recovery in hind limb ischemia models